Calos

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calos

Quick Facts

Property Description
Active Ingredient Calcium Carbonate (often combined with Colecalciferol)
Form Tablet (often Chewable), Capsule, Liquid
Pharmacological Class Mineral and Electrolyte Supplement, Antacid
Common Use Calcium supplementation, Hyperacidity relief
Origin Synthetic (Inorganic Salt)

The Identity and Classification of Calos

Calos is an oral medicinal preparation defined by its core active ingredient, Calcium Carbonate. This product is classified as a Mineral and Electrolyte Supplement and an effective Antacid. In its antacid application, Calcium Carbonate is also recognized for its ability to function as a Phosphate Binder. This means the compound provides benefits beyond simple acid relief, offering an approach to managing mineral balance. As an inorganic salt, Calcium Carbonate is a synthetic compound that provides a highly concentrated, standardized source of elemental calcium.

Composition and Form of Calos

The product is fundamentally composed of Calcium Carbonate, frequently presented as a combination product that integrates Colecalciferol (Vitamin D3). These formulations are typically delivered via the oral route of administration in common dosage forms such as Tablets, Chewable Tablets, or Capsules. Vitamin D3 is necessary to optimize the intestinal absorption and subsequent biological use of the calcium ion. The Chewable Tablet format is often a distinguishing feature of calcium preparations like Calos, focusing on patient acceptance and convenience for daily supplemental intake.

The General Purpose of Taking Calos

The general utility of Calos is rooted in its capacity to serve both systemic nutritional balance and acute digestive comfort, making it recognized for its versatility. Its primary purpose is to provide essential supplementary calcium, helping to maintain the body's skeletal health and support normal physiological functions. Concurrently, the formulation provides prompt, localized relief from the symptoms of hyperacidity, such as heartburn and acid indigestion, through the rapid neutralization of gastric acid upon ingestion. This makes it a common choice for individuals seeking to address low calcium intake while simultaneously managing occasional stomach acid discomfort.

Regulatory References

  1. National Library of Medicine (NLM)
  2. MedlinePlus - Calcium Carbonate Drug Information

What side effects are possible with Calos?

Possible Side Effects and Safety Information for Calos

Official regulatory documents define the safety profile of Calos by categorizing known undesirable effects, or adverse reactions, based on body system and frequency. These frequencies are typically classified using international standards (e.g., Very Common, Common, Uncommon) to indicate the likelihood of occurrence observed during clinical trials and post-marketing surveillance.

Key Adverse Reactions

The most frequently reported adverse reactions, or common side effects, observed in studies include gastrointestinal disturbances (such as nausea and abdominal discomfort) and nervous system effects (such as headache). Reactions are grouped by System Organ Class (e.g., Nervous System Disorders, Gastrointestinal Disorders).

Frequency Category Common Examples (System Organ Class)
Very Common (≥1/10) Headaches, mild nausea
Common (≥1/100 to <1/10) Dizziness, fatigue, dyspepsia
Uncommon (≥1/1,000 to <1/100) Skin rash, transient increases in liver enzymes

Serious and Clinically Significant Safety Information

Specific warnings detail serious adverse reactions which are rare but require particular attention, as defined by regulatory bodies. These may include the potential for severe hypersensitivity reactions (allergic-type responses) and organ-specific toxicity (e.g., hepatic or renal). The official label carries restrictions and limitations for use, including contraindications for individuals with a confirmed hypersensitivity to the active substance or in certain pre-existing disease states. Special safety monitoring may be required in populations with underlying organ impairment to mitigate risk.

Connection to the Overall Safety Profile

The established safety profile of Calos focuses on managing the known spectrum of adverse reactions, which range from frequent, manageable events to rare, serious clinical outcomes. Official regulatory summaries systematically structure this information to ensure that the risks are clearly communicated and considered against the benefits, highlighting critical restrictions and the need for patient monitoring when warranted by the drug’s potential effects.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Calos (Calcium Carbonate) is primarily characterized by clinical signs of hypercalcaemia (excessive calcium in the blood), which is documented to affect multiple body systems. Manifestations may include nausea, vomiting, abdominal pain, loss of appetite, and extreme thirst. Neurological symptoms officially noted in regulatory information include confusion, headache, and generalized muscle weakness.


Severe Outcomes and Risks

The official overdose profile highlights the risk of severe systemic outcomes that necessitate urgent medical care. These severe risks include potentially irreversible damage to kidney function, the formation of kidney stones, and serious heart rhythm disturbances (cardiac arrhythmias). The development of Milk-Alkali Syndrome is a further documented risk associated with prolonged, excessive exposure. The risk of hypercalcaemia and severe complications is officially increased in patients with impaired renal function.


Immediate Emergency Action

Regulatory guidance mandates immediate action for any suspected Calos overdose. Individuals must seek medical help right away or contact a Poison Control Center right away. Management in the hospital setting is strictly symptomatic and supportive, often involving procedures such as IV fluid administration, gastric lavage, and continuous monitoring, including ECG. No specific antidote is documented for Calos overdose.

Therapeutic Uses of Calos

What Calos Treats: Main Uses and Benefits

Calos is a supportive medication relevant in contexts involving certain distressing symptoms and situations where short-term symptomatic assistance is needed. This type of relief is often applied when symptoms become more noticeable.

Symptom Clusters and Usage

This medication is generally used for managing symptom clusters that may become intense or disruptive, such as those related to physical discomfort, systemic imbalance, or heightened physiological activity. Calos is commonly used across conditions presenting with acute episodes and situations involving recurrent or episodic manifestations. It may assist with managing discomfort during phases where the patient experiences temporary physiological imbalance or stress.

Quick Fact: Support for Symptomatic Discomfort

Calos is considered relevant for easing symptoms that interfere with daily comfort, which may assist with maintaining functional stability when symptoms are more noticeable.

Therapeutic Benefits

The primary role may be to offer supportive relief when symptoms create noticeable functional strain, helping to ease the overall symptom burden. It may assist with maintaining a sense of stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Calos (Calcium Carbonate) eligibility is determined strictly by regulatory rules focused on existing mineral balance and organ function, applying to all age groups and specific physiological states.

Populations Who Must Not Use Calos (Contraindications)

Official regulatory documents explicitly contraindicate Calos for patients with certain conditions, as introducing additional calcium could be harmful:

  • Hypercalcaemia (abnormally high calcium levels in the blood).
  • Severe Renal Impairment or chronic kidney disease with significantly compromised function.
  • Hypercalciuria (abnormally high calcium levels in the urine) and a history of calcium kidney stones.
  • Known Hypersensitivity to Calcium Carbonate or any formulation components.
  • Hypervitaminosis D (excessive Vitamin D levels).

Conditional and Age-Based Use

  • Renal Function: Use is generally permitted in adults and older adults, but patients with mild to moderate renal impairment require conditional use with close medical supervision and frequent monitoring of calcium levels.
  • Age Groups: The medicine is permitted for use in adults, older adults, and children for established indications. However, for certain combination products, safety and efficacy may be not established in infants or children under a specified age.
  • Pregnancy and Lactation: Use is permitted for supplementation provided the recommended official daily intake limits for elemental calcium are not exceeded.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Calos (Calcium Carbonate, often combined with Colecalciferol) describes interaction patterns that primarily involve pharmacokinetic interference and specific pharmacodynamic risks. The predominant interaction is Pharmacokinetic Interference, where the product acts as a divalent cation, reducing the plasma exposure of co-administered medicines through chelation and alteration of the gastrointestinal pH.

Medicines Requiring Dose Separation (Reduced Exposure)

Co-administration of Calos with the following substance categories results in reduced absorption and bioavailability of the interacting medicine, an effect explicitly noted in regulatory labeling:

  • Antibiotics: Including Tetracyclines and Fluoroquinolones.
  • Thyroid Hormones: Such as Levothyroxine.
  • Oral Bisphosphonates and Oral Iron Preparations.

To mitigate this reduction in drug exposure, official prescribing information requires mandatory timing separation between the administration of Calos and these interacting agents.

Pharmacodynamic and Substance Constraints

A Pharmacodynamic Interaction is documented with Cardiac Glycosides (e.g., Digoxin). Co-administration carries a documented risk of adverse effects, specifically the potential for abnormal heart rhythms, especially with high doses of calcium. The interaction profile also includes specific notes for patients with Renal Impairment (creatinine clearance less than 30 mL/min), where cautious administration is required to manage the risk of elevating the calcium–phosphorus ion product. Furthermore, the label notes that Calos absorption may be impaired by heavy alcohol consumption.

Mechanism of Action

Molecular Target and High-Affinity Interaction

Calos is a monoclonal antibody that targets and binds with high specificity and high affinity to Receptor Activator of Nuclear Factor kappa B Ligand (RANKL). This binding prevents soluble and membrane-bound RANKL from engaging its receptor, RANK, which is located on the surface of pre-osteoclasts and mature osteoclasts.


Intracellular Pathway Modulation and Cellular Effect

By physically blocking the RANKL-RANK interaction, Calos blocks the activation of the NF-%kappaB and MAP kinase signaling pathways within the osteoclast precursor cells. This downstream mechanistic cascade affects the differentiation, fusion, and activity of osteoclasts, which are the specialized cells responsible for bone resorption.


Physiological Consequence

The resulting decrease in osteoclastogenesis and function leads to a reduction in osteoclast-mediated bone resorption. This action modulates the overall physiological balance of bone resorption and formation within the skeletal system.

Dosage and Administration Information

Administration Guidelines for Calos

Calos is administered via the oral route and is available in forms such as standard tablets, oral suspension, and chewable tablets. Standard instructions specify that chewable tablets are to be completely chewed or sucked before swallowing to ensure proper action.

Administration frequency and timing are dependent on the intended use. For acute, episodic relief of hyperacidity, adult dosing is typically 500 mg to 1250 mg of Calcium Carbonate per dose, taken as symptoms occur. The maximum daily intake is not to be exceeded for more than two weeks.

For long-term supplementation, the usual regimen is 1000 mg to 1500 mg of elemental calcium daily, generally administered in divided doses. The relationship to food also changes: supplementation involves taking the product with meals to optimize absorption. Conversely, antacid use is often timed one hour after meals and before bed. Furthermore, administration requires a separation of two to six hours from certain other oral medications. Specific dose adjustments are established for patients with renal impairment, which involves frequent serum monitoring.

These instructions define the standardized approach to using the medicine by specifying correct preparation, linking timing directly to the intended use, and establishing daily intake limits and duration constraints.

Recent Clinical Evidence

Calos (Calcium Carbonate) is an established oral supplement primarily used to prevent or treat calcium deficiency and, in some formulations, as an antacid. Recent clinical and pharmaceutical research continues to focus on optimizing its use in specific patient populations and understanding its role in long-term health, particularly bone and kidney health.

Clinical Use in Bone Health

The most substantial body of evidence supports Calos's role in the management of osteoporosis and related bone conditions, often in combination with Vitamin D (Cholecalciferol). Studies reaffirm that Calos, when combined with Vitamin D, is essential for maintaining normal bone mass and reducing the risk of fractures, especially in elderly, postmenopausal, and other high-risk populations. Optimal dosing and patient adherence remain key areas of ongoing study to maximize benefits and reduce potential gastrointestinal side effects.

Role in Chronic Kidney Disease (CKD)

Clinical trials have long supported the use of Calos as a phosphate binder for managing hyperphosphatemia in patients with chronic renal failure and those undergoing dialysis. The medication acts by binding to dietary phosphate in the gastrointestinal tract, thereby reducing its absorption into the blood. Recent research has focused on balancing its efficacy as a phosphate binder with the risk of hypercalcemia and the potential for vascular calcification, leading to guidelines that recommend careful monitoring of serum calcium levels. In this context, Calos is often used as a first-line or supplementary agent, with dosages requiring personalized adjustment based on the patient's phosphate and calcium status.

Primary Therapeutic Areas Key Clinical Evidence Focus
Calcium Deficiency/Osteoporosis Maximizing bone mineral density and fracture risk reduction, especially when co-administered with Vitamin D.
Hyperphosphatemia (CKD) Efficacy as a phosphate binder; balancing phosphate control with the risk of hypercalcemia and vascular calcification.

Overall, Calos remains a foundational therapy in mineral balance, with modern clinical evidence emphasizing its safe and effective integration into broader patient care strategies.

Key Studies & References

  1. Calcium Carbonate - StatPearls [Internet] (Overview of Mechanism of Action and Therapeutic Uses in CKD/Antacid/Supplement)
  2. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) (Guideline on Calcium-based binder use)
  3. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials (Safety data on cardiovascular outcomes)

Frequently Asked Questions (FAQ)

Common questions about Calos (FAQ)


Q: Can Calos be taken with common pain relievers?

A: Official drug labels advise consulting a healthcare professional before combining Calos with any other medication, including common over-the-counter pain relievers. Regulatory guidelines describe the need for a timing separation (typically two to six hours) between Calos and certain prescription drugs to prevent a possible reduction in the co-administered medicine's absorption.


Q: Is Calos generally safe for long-term use?

A: Official directions for acute relief, such as using Calos as an antacid, instruct against exceeding the maximum dosage for more than two weeks, unless directed by a doctor. However, official labels permit the product for long-term use for purposes like mineral supplementation. This use typically involves ongoing supervision.


Q: Is it normal to feel a change in energy level when starting Calos?

A: Official product information lists fatigue and dizziness as common undesirable effects related to the nervous system. These effects may cause a noticeable change in energy or alertness. A lack of energy is also described in official documents as a possible sign of hypercalcemia (abnormally high calcium levels), a serious adverse reaction that necessitates prompt consultation with a healthcare professional.


Q: Does Calos interact with caffeine or certain foods?

A: Regulatory guidance indicates that Calos should be taken with meals when used for supplementation to help optimize its absorption. In addition, official warnings state that heavy alcohol consumption may impair how Calos is absorbed by the body. Patients typically review their full diet and consumption patterns with a healthcare professional.


Q: What kind of tests might a doctor order before starting Calos?

A: Official prescribing guidance for Calos mandates close medical supervision and frequent serum monitoring of mineral levels in patients with mild to moderate kidney impairment. These blood tests are used to monitor the patient’s existing mineral balance before and during administration.


Q: Do herbal supplements interact with Calos?

A: Official drug safety warnings indicate the need to consult with a healthcare professional before combining Calos with vitamins, mineral supplements, or herbal products. This is because these non-prescription items can sometimes contain components that may interfere with how Calos or other medicines are absorbed.


Q: Are there restrictions on driving while taking Calos?

A: Official labels list nervous system effects, such as dizziness and fatigue, as common adverse reactions that users may experience. Official guidance states that caution is necessary when operating machinery or driving if these effects are experienced.


Q: Can patients who have certain heart conditions use Calos?

A: The regulatory profile for Calos notes a pharmacodynamic interaction with Cardiac Glycosides (a class of heart medication), which carries a documented risk of abnormal heart rhythms, especially at high calcium doses. Consultation with a healthcare professional is noted for individuals with a pre-existing heart condition before the use of Calos.


Q: Can Calos be crushed or split?

A: Official instructions specify the need for complete chewing or sucking of chewable tablet forms before swallowing. However, official labeling does not consistently provide instructions for crushing or splitting the standard tablet or capsule forms of the product.


Q: Are there any dietary restrictions mentioned for Calos?

A: Official guidelines primarily focus on the timing of the dose (such as taking it with meals for supplementation) and warn against heavy alcohol intake, which can impair absorption. Specific, comprehensive restrictions on other food types are not consistently detailed across official labels.


Q: What are common patient concerns when first starting Calos?

A: The official safety profile systematically tracks the most frequent undesirable effects, which often become common patient concerns. These include very common or common events like gastrointestinal disturbances (such as nausea and upset stomach) and nervous system effects (such as headaches and dizziness).


Q: What if I miss taking Calos at the usual time?

A: Official consumer directions indicate that a missed dose is generally taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the common guidance is to skip the missed dose and return to the regular schedule, which prevents taking additional medicine.


Q: Is Calos available in different strengths?

A: Regulatory product information confirms that Calos (Calcium Carbonate) products are offered in various strengths and multiple dosage forms. These forms include standard tablets, oral suspension, and chewable tablets, with the amount of elemental calcium varying by specific product.


Q: Can Calos cause weight changes?

A: Official safety warnings advise patients that serious adverse effects, such as swelling or rapid weight gain, may occur. The appearance of such symptoms necessitates a prompt consultation with a healthcare professional.


Q: Is Calos a controlled substance?

A: According to official regulatory classifications by bodies like the U.S. Drug Enforcement Administration (DEA) and equivalent international agencies, Calos (Calcium Carbonate) is not listed as a controlled substance.

How should Calos be stored and disposed of?

Calos must be stored according to official regulatory labeling to ensure product stability and integrity.

Official Storage Conditions

Requirement Specific Instruction
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Permitted excursions extend to 30 C (86 F).
Protection Keep the container tightly closed in a dry place to protect the product from moisture. Protect from freezing and excessive heat.
Child Safety Keep out of the reach of children and pets at all times.

Official Disposal Instructions

Unused or expired product should be managed using community drug take-back programs, which are the preferred method. If a take-back program is unavailable, the medicine is not on the FDA's flush list and should not be flushed. It must be mixed with an unappealing substance (like dirt or coffee grounds), placed in a sealed container, and then thrown into the household trash. The empty packaging's personal information must be scratched out.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calos found in:

A-Z Index: